We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-29.4%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$853M
AUM Growth
-$21.7M
Cap. Flow
+$306M
Cap. Flow %
35.89%
Top 10 Hldgs %
46.26%
Holding
212
New
44
Increased
26
Reduced
27
Closed
63

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.63%
2 Healthcare 17.83%
3 Communication Services 10.12%
4 Financials 8%
5 Materials 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRX
101
DELISTED
Chimerix, Inc.
CMRX
$475K 0.06%
330,061
ECOLW
102
DELISTED
US Ecology, Inc. Warrant
ECOLW
$464K 0.05%
105,350
CYPH
103
Cypherpunk Technologies Inc
CYPH
$71.7M
$437K 0.05%
27,647
+12,633
+84% +$245K
FBIO icon
104
Fortress Biotech
FBIO
$92M
$379K 0.04%
13,333
-5,191
-28% -$172K
ELDN icon
105
Eledon Pharmaceuticals
ELDN
$267M
$369K 0.04%
52,567
+35,900
+215% +$343K
IYR icon
106
CALL
iShares US Real Estate ETF
IYR
$4.63B
$348K 0.04%
+5,000
New +$443K
BROGW
107
DELISTED
Brooge Holdings Limited Warrant expiring 12/20/2024
BROGW
$280K 0.03%
+349,402
New +$316K
SONG
108
DELISTED
Akazoo SA
SONG
$279K 0.03%
99,812
-188
-0.2% -$795
NESRW
109
DELISTED
National Energy Services Reunited Corp. Warrant
NESRW
$239K 0.03%
725,000
ARCT icon
110
Arcturus Therapeutics
ARCT
$173M
$229K 0.03%
16,855
+563
+3% +$7.21K
PVLA
111
Palvella Therapeutics
PVLA
$2.23B
$205K 0.02%
1,125
LTRYW icon
112
Sports Entertainment Gaming Global Corp Warrants
LTRYW
$785
$189K 0.02%
1,993,750
IGICW
113
DELISTED
International General Insurance Holdings Ltd. Warrants expiring 03/17/2025
IGICW
$189K 0.02%
+450,000
New +$217K
NRK icon
114
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$901M
$180K 0.02%
+14,400
New +$193K
SONGW
115
DELISTED
Akazoo SA Warrant
SONGW
$160K 0.02%
489,700
CIVI
116
DELISTED
Civitas Resources
CIVI
$140K 0.02%
+12,500
New +$210K
DSX icon
117
Diana Shipping
DSX
$312M
$138K 0.02%
133,348
-27,436
-17% -$45.6K
TCON
118
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$128K 0.02%
3,750
-3,000
-44% -$174K
LGC.WS
119
DELISTED
Legacy Acquisition Corp. Warrants, exercisable for one-half of one share of Class A Common Stock for
LGC.WS
$125K 0.01%
500,000
LSEAW
120
DELISTED
Landsea Homes Corporation Warrant
LSEAW
$117K 0.01%
450,000
KLR.WS
121
DELISTED
Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share
KLR.WS
$115K 0.01%
135,000
-15,000
-10% -$15.7K
PBFX
122
DELISTED
PBF LOGISTICS LP
PBFX
$106K 0.01%
+15,663
New +$262K
ONCS
123
DELISTED
OncoSec Medical Incorporated
ONCS
$102K 0.01%
3,633
MFAC.WS
124
DELISTED
Megalith Financial Acquisition Corp. Warrants, each warrant exercisable for one share of Class A Com
MFAC.WS
$88K 0.01%
400,000
FMCIW
125
DELISTED
Forum Merger II Corporation Warrant
FMCIW
$81K 0.01%
300,000

Similar funds

683 Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, 683 Capital Management held 212 positions worth $853M, down 2.5% from $874M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

683 Capital Management deployed $306M of net new capital in Q1 2020, opening 44 new positions and adding to 26 existing holdings. Its largest new stake was Just Eat Takeaway.com N.V. American Depositary Shares: 307,911 shares worth $25.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 22% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $6.35M trimmed.

  • 683 Capital Management's largest Q1 2020 buy was Just Eat Takeaway.com N.V. American Depositary Shares: 307,911 shares worth $25.1M.
  • 683 Capital Management added most to Capital One in Q1 2020, an estimated $47.5M increase.
  • 683 Capital Management's biggest Q1 2020 reduction was Alnylam Pharmaceuticals, cutting an estimated $6.35M.
  • 683 Capital Management fully exited Redhill Biopharma in Q1 2020, selling an estimated $6.28M.
  • 683 Capital Management's ten largest holdings make up 46% of its $853M portfolio in Q1 2020.
  • 683 Capital Management opened 44 new positions and closed 63 in Q1 2020.
  • 683 Capital Management's portfolio value fell 2.5% quarter-over-quarter to $853M.

Based on 683 Capital Management's 13F filing for Q1 2020, filed 15 May 2020.